Jakob Dal
Overview
Explore the profile of Jakob Dal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matthesen A, Rosendal C, Christensen E, Beckmann H, Klit F, Nikontovic A, et al.
Pituitary
. 2025 Mar;
28(2):42.
PMID: 40082297
Purpose: We aimed to evaluate the risk of psychiatric disorders through a retrospective cohort study comparing acromegaly and non-functioning pituitary adenomas (NFPAs) and a meta-analysis of existing literature. Methods: The...
2.
Rosendal C, Christiansen Arlien-Soborg M, Nielsen E, Feltoft C, Rasmussen A, Andersen M, et al.
Eur J Endocrinol
. 2025 Mar;
PMID: 40079357
Objective: Acromegaly is associated with multiple musculoskeletal complications that affect quality of life and work ability. We aimed to examine the risk of osteoarthritis, musculoskeletal surgery (incl. joint replacement), osteoporosis,...
3.
Loughrey P, Mothojakan N, Iacovazzo D, Arni A, Aflorei E, Arnaldi G, et al.
Eur J Endocrinol
. 2025 Mar;
PMID: 40070360
Objective: Heterozygous germline loss-of-function variants in AIP are associated with young-onset growth hormone and/or prolactin-secreting pituitary tumours. However, the pathogenic role of the c.911G>A; p.(Arg304Gln) (R304Q) AIP variant has been...
4.
Nielsen M, Frejlev H, Vestermark A, Larsen L, Pietraszek A, Dal J, et al.
Diabetes Spectr
. 2025 Feb;
38(1):41-48.
PMID: 39959531
Objective: This qualitative study explored the challenges and knowledge gaps among Danish youth with type 1 diabetes and subsequently introduced an information program to empower these youth in their diabetes...
5.
Trifanescu R, Dal J
Front Endocrinol (Lausanne)
. 2024 Nov;
15:1503633.
PMID: 39534256
No abstract available.
6.
Klit F, Dal J, Andersen S, Nikontovic A, Vestergaard P, Karmisholt J
Clin Epidemiol
. 2024 Oct;
16:699-705.
PMID: 39397888
Purpose: Graves' disease (GD) is one of the most common causes of thyrotoxicosis. It has been proposed to identify incident GD by using the GD-specific code, E05.0, of the 10th...
7.
Gjersdal E, Larsen L, Ettrup K, Vestergaard P, Nielsen E, Karmisholt J, et al.
Pituitary
. 2024 Aug;
27(5):723-730.
PMID: 39088138
Purpose: Patients with hypothalamic pathology often develop hypothalamic obesity, causing severe metabolic alterations resulting in increased morbidity and mortality. Treatments for hypothalamic obesity have not proven very effective, although the...
8.
Arlien-Soborg M, Dal J, Heck A, Stochholm K, Husted E, Feltoft C, et al.
Clin Endocrinol (Oxf)
. 2024 Jun;
101(3):263-273.
PMID: 38865284
Objective: Acromegaly is associated with increased morbidity and mortality if left untreated. The therapeutic options include surgery, medical treatment, and radiotherapy. Several guidelines and recommendations on treatment algorithms and follow-up...
9.
Rosendal C, Christiansen Arlien-Soborg M, Nielsen E, Andersen M, Feltoft C, Klose M, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1380436.
PMID: 38638137
Objective: To study the time-dependent changes in disease features of Danish patients with acromegaly, including treatment modalities, biochemical outcome, and comorbidities, with a particular focus on cancer and mortality. Methods:...
10.
Rosendal C, Christiansen Arlien-Soborg M, Nielsen E, Andersen M, Feltoft C, Kistorp C, et al.
Rev Endocr Metab Disord
. 2024 Feb;
25(4):691-705.
PMID: 38337125
Acromegaly is a rare disease and thus challenging to accurately quantify epidemiologically. In this comprehensive literature review, we compare different approaches to studying acromegaly from an epidemiological perspective and describe...